Messaging Strategies for Vaping
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to identify the most effective way to communicate the risks of vaping to young adults using various message styles and sources, such as experts or peers. Participants will receive either one-sided messages, presenting a single viewpoint, or two-sided messages, offering both sides of the argument. The trial targets young adults aged 18-24 who either vape or are at risk of starting. As an unphased trial, it provides a unique opportunity for participants to contribute to important research that could influence future public health messaging.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that these messaging strategies are safe for young adults?
Research shows that vaping, especially with e-cigarettes, raises safety concerns. E-cigarettes often contain nicotine, which can be addictive and harmful. Studies have found that using both traditional cigarettes and e-cigarettes may increase the risk of lung cancer more than using regular cigarettes alone.
Discussions about vaping focus on how information is shared to educate people about the risks of e-cigarettes. Since no direct medical treatment is involved, the emphasis is on understanding and changing behavior rather than addressing side effects from a medical procedure.
Overall, understanding the potential harms of vaping and how information can guide decisions is crucial. The information provided aims to promote learning and awareness, not serve as a medical treatment.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it's exploring new ways to educate people about the risks of e-cigarettes through messaging strategies. Unlike traditional health campaigns that deliver a one-size-fits-all message, this trial is testing how different sources and sides of a message can influence understanding and behavior. By tailoring messages to be either one-sided or two-sided and testing different sources, such as healthcare professionals versus peers, this approach aims to see which method is more effective in changing perceptions about vaping. This could lead to more impactful public health strategies and ultimately help reduce e-cigarette use.
What evidence suggests that this trial's messaging strategies could be effective for vaping?
Research shows that effective communication can change vaping habits in young adults. This trial will explore different messaging strategies. Participants in the "Sidedness" arm will receive e-cigarette education messages manipulated in one of two sidedness types, while those in the "Source" arm will receive messages manipulated in one of two source types. One study found that text message programs helped people aged 18 to 24 quit vaping more effectively than surveys alone. Another study found that text-only warnings about e-cigarettes improved understanding of the risks. Additionally, research on social media platforms like TikTok showed that emotional messages can influence young people's decision to stop vaping. Overall, these findings suggest that well-designed messages can significantly help reduce e-cigarette use among youth.678910
Who Is on the Research Team?
Donghee N Lee, PhD
Principal Investigator
UMass Chan Medical School
Are You a Good Fit for This Trial?
This trial is for US residents aged 18-24 who speak English fluently. Participants must have either used e-cigarettes in the past month or not used them but are open to trying. It's aimed at understanding how young adults respond to different vaping messages.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive e-cigarette education messages manipulated in sidedness and source types
Follow-up
Participants are monitored for responses to e-cigarette education messages
What Are the Treatments Tested in This Trial?
Interventions
- E-cigarette Message Source and Presentation
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Massachusetts, Worcester
Lead Sponsor
National Cancer Institute (NCI)
Collaborator